SAFE-PLASMA Protocol
Key requirements
- What the notice asks for: The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc.
- Where: MD, 21702, USA
- Response deadline: Nov 16, 2026 · 2:00 PM ET — see the official posting for submission instructions and format.
Full details
- Solicitation number
- HT9427-27-SSN-701
- Notice type
- Sources Sought
- NAICS code
- 541715
- Place of performance
- MD, 21702, USA
- Posted
- Nov 10, 2026
- Response deadline
- Nov 16, 2026 · 2:00 PM ET
Description
The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration�s requirements for EZPLAZ� approval.
Buyer contact
Primary contact:
Jamie Diggs
Email: jamie.l.diggs.civ@health.mil
Source: SAM.gov, the U.S. government's official contract-opportunities system. Details above are reproduced from the official notice — always verify on the official posting before bidding.